These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28468837)
1. Crypt Organoid Culture as an in Vitro Model in Drug Metabolism and Cytotoxicity Studies. Lu W; Rettenmeier E; Paszek M; Yueh MF; Tukey RH; Trottier J; Barbier O; Chen S Drug Metab Dispos; 2017 Jul; 45(7):748-754. PubMed ID: 28468837 [TBL] [Abstract][Full Text] [Related]
2. Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11). Chen S; Yueh MF; Bigo C; Barbier O; Wang K; Karin M; Nguyen N; Tukey RH Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19143-8. PubMed ID: 24191041 [TBL] [Abstract][Full Text] [Related]
3. A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation. Cai H; Nguyen N; Peterkin V; Yang YS; Hotz K; La Placa DB; Chen S; Tukey RH; Stevens JC Drug Metab Dispos; 2010 May; 38(5):879-86. PubMed ID: 20124398 [TBL] [Abstract][Full Text] [Related]
4. Real time analysis of metabolic profile in ex vivo mouse intestinal crypt organoid cultures. Bas T; Augenlicht LH J Vis Exp; 2014 Nov; (93):e52026. PubMed ID: 25406992 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy. Grabinger T; Luks L; Kostadinova F; Zimberlin C; Medema JP; Leist M; Brunner T Cell Death Dis; 2014 May; 5(5):e1228. PubMed ID: 24832600 [TBL] [Abstract][Full Text] [Related]
6. Screening of Intestinal Crypt Organoids: A Simple Readout for Complex Biology. Ley S; Galuba O; Salathe A; Melin N; Aebi A; Pikiolek M; Knehr J; Carbone W; Beibel M; Nigsch F; Roma G; d'Ario G; Kirkland S; Bouchez LC; Gubser Keller C; Bouwmeester T; Parker CN; Ruffner H SLAS Discov; 2017 Jun; 22(5):571-582. PubMed ID: 28345372 [TBL] [Abstract][Full Text] [Related]
7. Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells. Basseville A; Preisser L; de Carné Trécesson S; Boisdron-Celle M; Gamelin E; Coqueret O; Morel A Mol Cancer; 2011 Jul; 10():80. PubMed ID: 21733184 [TBL] [Abstract][Full Text] [Related]
8. Long-term culture-induced phenotypic difference and efficient cryopreservation of small intestinal organoids by treatment timing of Rho kinase inhibitor. Han SH; Shim S; Kim MJ; Shin HY; Jang WS; Lee SJ; Jin YW; Lee SS; Lee SB; Park S World J Gastroenterol; 2017 Feb; 23(6):964-975. PubMed ID: 28246470 [TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus. Ciotti M; Basu N; Brangi M; Owens IS Biochem Biophys Res Commun; 1999 Jun; 260(1):199-202. PubMed ID: 10381366 [TBL] [Abstract][Full Text] [Related]
10. Murine intestinal organoids resemble intestinal epithelium in their microRNA profiles. Ohsaka F; Sonoyama K Biosci Biotechnol Biochem; 2018 Sep; 82(9):1560-1567. PubMed ID: 29739279 [TBL] [Abstract][Full Text] [Related]
11. Establishment of 3D Intestinal Organoid Cultures from Intestinal Stem Cells. Sugimoto S; Sato T Methods Mol Biol; 2017; 1612():97-105. PubMed ID: 28634937 [TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980 [TBL] [Abstract][Full Text] [Related]
13. Development of organoid-based drug metabolism model. Park E; Kim HK; Jee J; Hahn S; Jeong S; Yoo J Toxicol Appl Pharmacol; 2019 Dec; 385():114790. PubMed ID: 31678242 [TBL] [Abstract][Full Text] [Related]
14. Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro. Mallick P; Basu S; Moorthy B; Ghose R Toxicol In Vitro; 2017 Jun; 41():75-82. PubMed ID: 28242239 [TBL] [Abstract][Full Text] [Related]
15. Brief summary of the current protocols for generating intestinal organoids. Miura S; Suzuki A Dev Growth Differ; 2018 Aug; 60(6):387-392. PubMed ID: 30039581 [TBL] [Abstract][Full Text] [Related]
16. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720 [TBL] [Abstract][Full Text] [Related]
17. Mensenchymal stem cells can delay radiation-induced crypt death: impact on intestinal CD44(+) fragments. Chang PY; Jin X; Jiang YY; Wang LX; Liu YJ; Wang J Cell Tissue Res; 2016 May; 364(2):331-44. PubMed ID: 26613604 [TBL] [Abstract][Full Text] [Related]
18. Organoids as an ex vivo model for studying the serotonin system in the murine small intestine and colon epithelium. Tsuruta T; Saito S; Osaki Y; Hamada A; Aoki-Yoshida A; Sonoyama K Biochem Biophys Res Commun; 2016 May; 474(1):161-167. PubMed ID: 27105910 [TBL] [Abstract][Full Text] [Related]
19. Permeability analyses and three dimensional imaging of interferon gamma-induced barrier disintegration in intestinal organoids. Bardenbacher M; Ruder B; Britzen-Laurent N; Schmid B; Waldner M; Naschberger E; Scharl M; Müller W; Günther C; Becker C; Stürzl M; Tripal P Stem Cell Res; 2019 Mar; 35():101383. PubMed ID: 30776676 [TBL] [Abstract][Full Text] [Related]